Cargando…
Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer
The cellular and molecular basis of stromal cell recruitment, activation and crosstalk in carcinomas is poorly understood, limiting the development of targeted anti-stromal therapies. In mouse models of triple negative breast cancer (TNBC), Hedgehog ligand produced by neoplastic cells reprograms can...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057940/ https://www.ncbi.nlm.nih.gov/pubmed/30042390 http://dx.doi.org/10.1038/s41467-018-05220-6 |
_version_ | 1783341602002960384 |
---|---|
author | Cazet, Aurélie S. Hui, Mun N. Elsworth, Benjamin L. Wu, Sunny Z. Roden, Daniel Chan, Chia-Ling Skhinas, Joanna N. Collot, Raphaël Yang, Jessica Harvey, Kate Johan, M. Zahied Cooper, Caroline Nair, Radhika Herrmann, David McFarland, Andrea Deng, Niantao Ruiz-Borrego, Manuel Rojo, Federico Trigo, José M. Bezares, Susana Caballero, Rosalía Lim, Elgene Timpson, Paul O’Toole, Sandra Watkins, D. Neil Cox, Thomas R. Samuel, Michael S. Martín, Miguel Swarbrick, Alexander |
author_facet | Cazet, Aurélie S. Hui, Mun N. Elsworth, Benjamin L. Wu, Sunny Z. Roden, Daniel Chan, Chia-Ling Skhinas, Joanna N. Collot, Raphaël Yang, Jessica Harvey, Kate Johan, M. Zahied Cooper, Caroline Nair, Radhika Herrmann, David McFarland, Andrea Deng, Niantao Ruiz-Borrego, Manuel Rojo, Federico Trigo, José M. Bezares, Susana Caballero, Rosalía Lim, Elgene Timpson, Paul O’Toole, Sandra Watkins, D. Neil Cox, Thomas R. Samuel, Michael S. Martín, Miguel Swarbrick, Alexander |
author_sort | Cazet, Aurélie S. |
collection | PubMed |
description | The cellular and molecular basis of stromal cell recruitment, activation and crosstalk in carcinomas is poorly understood, limiting the development of targeted anti-stromal therapies. In mouse models of triple negative breast cancer (TNBC), Hedgehog ligand produced by neoplastic cells reprograms cancer-associated fibroblasts (CAFs) to provide a supportive niche for the acquisition of a chemo-resistant, cancer stem cell (CSC) phenotype via FGF5 expression and production of fibrillar collagen. Stromal treatment of patient-derived xenografts with smoothened inhibitors (SMOi) downregulates CSC markers expression and sensitizes tumors to docetaxel, leading to markedly improved survival and reduced metastatic burden. In the phase I clinical trial EDALINE, 3 of 12 patients with metastatic TNBC derived clinical benefit from combination therapy with the SMOi Sonidegib and docetaxel chemotherapy, with one patient experiencing a complete response. These studies identify Hedgehog signaling to CAFs as a novel mediator of CSC plasticity and an exciting new therapeutic target in TNBC. |
format | Online Article Text |
id | pubmed-6057940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60579402018-07-26 Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer Cazet, Aurélie S. Hui, Mun N. Elsworth, Benjamin L. Wu, Sunny Z. Roden, Daniel Chan, Chia-Ling Skhinas, Joanna N. Collot, Raphaël Yang, Jessica Harvey, Kate Johan, M. Zahied Cooper, Caroline Nair, Radhika Herrmann, David McFarland, Andrea Deng, Niantao Ruiz-Borrego, Manuel Rojo, Federico Trigo, José M. Bezares, Susana Caballero, Rosalía Lim, Elgene Timpson, Paul O’Toole, Sandra Watkins, D. Neil Cox, Thomas R. Samuel, Michael S. Martín, Miguel Swarbrick, Alexander Nat Commun Article The cellular and molecular basis of stromal cell recruitment, activation and crosstalk in carcinomas is poorly understood, limiting the development of targeted anti-stromal therapies. In mouse models of triple negative breast cancer (TNBC), Hedgehog ligand produced by neoplastic cells reprograms cancer-associated fibroblasts (CAFs) to provide a supportive niche for the acquisition of a chemo-resistant, cancer stem cell (CSC) phenotype via FGF5 expression and production of fibrillar collagen. Stromal treatment of patient-derived xenografts with smoothened inhibitors (SMOi) downregulates CSC markers expression and sensitizes tumors to docetaxel, leading to markedly improved survival and reduced metastatic burden. In the phase I clinical trial EDALINE, 3 of 12 patients with metastatic TNBC derived clinical benefit from combination therapy with the SMOi Sonidegib and docetaxel chemotherapy, with one patient experiencing a complete response. These studies identify Hedgehog signaling to CAFs as a novel mediator of CSC plasticity and an exciting new therapeutic target in TNBC. Nature Publishing Group UK 2018-07-24 /pmc/articles/PMC6057940/ /pubmed/30042390 http://dx.doi.org/10.1038/s41467-018-05220-6 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Cazet, Aurélie S. Hui, Mun N. Elsworth, Benjamin L. Wu, Sunny Z. Roden, Daniel Chan, Chia-Ling Skhinas, Joanna N. Collot, Raphaël Yang, Jessica Harvey, Kate Johan, M. Zahied Cooper, Caroline Nair, Radhika Herrmann, David McFarland, Andrea Deng, Niantao Ruiz-Borrego, Manuel Rojo, Federico Trigo, José M. Bezares, Susana Caballero, Rosalía Lim, Elgene Timpson, Paul O’Toole, Sandra Watkins, D. Neil Cox, Thomas R. Samuel, Michael S. Martín, Miguel Swarbrick, Alexander Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer |
title | Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer |
title_full | Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer |
title_fullStr | Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer |
title_full_unstemmed | Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer |
title_short | Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer |
title_sort | targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057940/ https://www.ncbi.nlm.nih.gov/pubmed/30042390 http://dx.doi.org/10.1038/s41467-018-05220-6 |
work_keys_str_mv | AT cazetaurelies targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT huimunn targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT elsworthbenjaminl targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT wusunnyz targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT rodendaniel targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT chanchialing targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT skhinasjoannan targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT collotraphael targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT yangjessica targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT harveykate targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT johanmzahied targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT coopercaroline targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT nairradhika targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT herrmanndavid targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT mcfarlandandrea targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT dengniantao targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT ruizborregomanuel targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT rojofederico targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT trigojosem targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT bezaressusana targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT caballerorosalia targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT limelgene targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT timpsonpaul targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT otoolesandra targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT watkinsdneil targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT coxthomasr targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT samuelmichaels targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT martinmiguel targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer AT swarbrickalexander targetingstromalremodelingandcancerstemcellplasticityovercomeschemoresistanceintriplenegativebreastcancer |